active pharmaceutical ingredients

Premium

Healthcare

01 March, 2021

Steadview Capital makes partial exit from bulk drugs firm

Alternative investment firm Steadview Capital has made back-to-back partial exits from portfolio companies taking advantage of the buoyant stock market ......

Premium

Healthcare

10 February, 2021

Bulk drugs hot up as US state pension fund piles into Steadview-backed API maker

A US state pension fund has invested in a Hyderabad-based active pharmaceutical ingredients (API) maker.  This is the latest in a ......

Premium

Healthcare

06 November, 2019

Why Indian bulk-drug makers are attracting greater investor interest

Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry executives ......

Premium

Healthcare

12 June, 2017

Symbiotec Pharmalab gets interest from new set of PE firms

Symbiotec Pharmalab Pvt. Ltd has attracted interest from a new set of global private equity investors, as majority owner Actis ......